Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    Prof. Pierre Guertin

    Prof. Pierre Guertin
    Laval University, Canada
    Email: pierre.guertin@crchudequebec.ulaval.ca
    Tel: +1 418-525-4444, pos
    Fax: +1 418-654-2753

    More Info.

    Editorial Board

    BEATA SARECKA-HUJAR
    phd
    Department of Pharmaceutical Technology
    Medical University of Silesia in Katowice
    Poland
    beatasarecka@poczta.onet.pl
    IJPSDR

    After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.


    Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

    Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.


    List of Publications:
    Selected articles of my authorship:
    1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

    2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

    3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

    4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

    5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

    6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

    7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

    8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

    9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

    10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

    11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

    12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

    13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

    14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

    15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

    16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

    17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

    18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

    19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

    20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

    21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

    22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.


    More Info.
    Mahmud Kajbaf
    Senior Research Scientist
    Drug Metabolism, Division of Aptuit
    Italy
    mahmud.kajbaf@aptuit.com
    IJPSDR

    Research Interest: Drug Metaboilism, Mass spectrometry, Pharmacokinetics and Pharmacodynamics, Medicine, Pharmacy.

    More Info.
    Agata Paneth
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    agata.paneth@umlub.pl
    IJPSDR

    Research Interest: Medicinal chemistry, Structure-activity relationship studies, Synthesis of heterocyclic compounds, Antimicrobial screening, Enzymatic studies.


    More Info.
    Waseem Kaialy
    Science and Engineering
    University of Wolverhampton
    UK
    w.kaialy@wlv.ac.uk
    IJPSDR

    Research Interest: Pharmaceutics, Pharmaceutical Sciences, Drugdelivery, Inhalation, Dosage forms, Particle engineering.

    More Info.
    Nicola Micale
    University of Messina
    Italy
    nmicale@unime.it
    IJPSDR

    Research Interest: Design, Synthesis and qualitative SAR of new anticonvulsant agents acting as non-competitive AMPA receptor antagonists (In collaboration with Dr. Li Niu, Chemistry Department, University at Albany, SUNY, Albany NY), Identifications and synthesis of new anti-cancer agents, Design and synthesis of peptidomimetics as protease inhibitors.

    More Info.
    Cui Yang
    Ethnic Drug Screening and Pharmacology Center
    Yunnan Minzu University
    China
    yangynni@163.com
    IJPSDR

    Research Interest: Cardiovascular pharmacology, New Therapeutic targets for atherosclerosis, hypertension and vasculogenesis, Screening of TCM and ethnic drugs.


    More Info.
    Francesca Borrelli
    Department of Pharmacy
    University of Naples Federico II
    Italy
    franborr@unina.it
    IJPSDR

    Research Interest: Therapeutic relevance of plant-derived compounds in the field of the gastrointestinal pathologies (IBD, cancer, etc.) and on the signal transduction mechanisms involved in their action.Moreover, Toxicological aspects of natural products are also studied.

    More Info.
    Mohammad-Ali Shahbazi
    Division of Pharmaceutical Technology
    University of Helsinki
    Finland
    m.a.shahbazi@helsinki.fi
    IJPSDR

    Research Interest: Biomaterials, Nanomedicine, Pharmaceutical Nanotechnology, Nanovaccines, Targeted drug delivery, Nanotoxicity, surface biofunctionalization, Cell-nanoparticle Interactions.

    More Info.
    Nian-Qiu Shi
    Department of Pharmaceutics School of Pharmacy Ji Lin Medical College
    China
    shinianqiu2009@163.com
    IJPSDR

    Research Interest: Targeting drug delivery systems (TDDS), Multifunctional nanocarriers or macromolecules have many advantages for diseases treatments. Our lab employs diverse targeting delivery systems including conjugate, liposomes and micelles to deliver anticancer drug or gene for tumor therapy. In this process, we unitize stimuli-responsive strategies (e.g. enzyme-responsive) to obtain the targeting therapy of tumor. Cell-penetrating peptides (CPPs) are also adopted to cross cellular barriers. Internalization mechinisms of CPPs or CPP-cargoes are also focused by us.

    More Info.
    Tomasz Plech
    Department of Organic Chemistry
    Medical University of Lublin
    Poland
    tomasz.plech@umlub.pl
    IJPSDR

    Research Interest: Synthesis of nitrogen- and sulfur-containng heterocycles, Design and synthesis of Novel anticonvulsant, Anticancer, Antibacterial and anti-toxoplasmosis drugs, Computer-aided drug Design, Chromatographic techniques for the analysis of the newly ynthesized compounds, (Q)SAR sudies.


    More Info.
    Lei Wang
    School of Pharmacy
    Queen s University Belfast
    UK
    l.wang@qub.ac.uk
    IJPSDR

    Research Interest: Natural drug discovery, Isolation, Physiological and pharmacological characterization of venom/toxin peptides and proteinswith animal tissues, Natural peptides and proteins analytical Chemistry, Mass spectrometry analysis, Molecular biology, Synthetic peptide analogues and their interaction with antibodies and receptors, Identification of novel drug targets, Biomarkers, Ion channel.

    More Info.
    Francis Ignatious
    Senior Scientific Investigator
    Glaxo Smith Kline
    USA
    Francis.2.Ignatious@gsk.com
    IJPSDR
    More Info.
    Xiaodong Zheng
    Department of Pathophysiology
    Harbin Medical University
    China
    xzheng2001@163.com
    IJPSDR

    Research Interest: Ophthalmology, Cataract Surger,Cornea, Refractive Eye Surgery, Keratoconus.


    More Info.
    Ramune Jacobsen
    Institute of Preventive Medicine Frederiksberg Hospital
    Denmark
    ramune.jacobsen@regionh.dk
    IJPSDR

    Research Interest: Outcomes of interventions in public health (health promotion, health services and disease, prevention).

    More Info.
    Tanveer A Wani
    Department of Pharmaceutical Chemistry
    King Saud University
    Saudi Arabia
    twani@ksu.edu
    IJPSDR

    Research Interest: Method development and validation of biosensors for estimation of Cancer Markers.

    More Info.
    View more
    mendeley

    A cross sectional study of alcohol consumption and risk factors

    DOI Logo 10.17352/ijpsdr.000032

    Published On: September 23, 2020 | Pages: 034 - 037

    Author(s): R Dinesh Kumar, J Kalaiselvi and Siva S*
    Abstract View Full Article View
    mendeley

    Developing analytical parameters and evaluation of thermo fisher urinary creatinine enzymatic method to implement in open system chemistry analyzers

    DOI Logo 10.17352/ijpsdr.000031

    Published On: September 16, 2020 | Pages: 030 - 033

    Author(s): Ashraf Mina*, Leah McNeice, Shanmugam Banukumar and Santiago Vazquez
    Abstract View Full Article View
    mendeley

    Development and optimization of mucoadhesive microballons of nizatidine for management of peptic ulcer

    DOI Logo 10.17352/ijpsdr.000030

    Published On: June 29, 2020 | Pages: 021 - 029

    Author(s): Seema Jain, Neha Jain, Mohan Lal Kor, Umesh Kumar Jain and Abhishek Kumar Jain*
    Abstract View Full Article View
    mendeley

    An overview on NMR spectroscopy based metabolomics

    DOI Logo 10.17352/ijpsdr.000029

    Published On: June 03, 2020 | Pages: 016 - 020

    Author(s): Nalini Kanta Sahoo*, G Tejaswini, Madhusmita Sahu and KS Muralikrishna
    Abstract View Full Article View
    mendeley

    Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

    DOI Logo 10.17352/ijpsdr.000028

    Published On: June 03, 2020 | Pages: 012 - 015

    Author(s): Monthon Lertcanawanichakul* and Kittisak Chawawisit
    Abstract View Full Article View
    mendeley

    Pharmaceutical Nanotechnology: A Therapeutic Revolution

    DOI Logo 10.17352/ijpsdr.000027

    Published On: May 05, 2020 | Pages: 009 - 011

    Author(s): Douglas Dourado*
    Abstract View Full Article View
    mendeley

    Regarding the measurement of therapeutic adherence

    DOI Logo 10.17352/ijpsdr.000026

    Published On: April 17, 2020 | Pages: 008 - 008

    Author(s): Sara Malo*
    Abstract View Full Article View
    mendeley

    Jaiphal Myristica fragrans (Houtt)-A promising seed for pharmaceutical industries

    DOI Logo 10.17352/ijpsdr.000025

    Published On: March 21, 2020 | Pages: 006 - 007

    Author(s): Ankita Chakravarty, Jai Gopal Sharma*
    Abstract View Full Article View
    mendeley

    Validation of spectrophotometric method for determination of esomeprazole and ciprofloxacin in their pure and dosage forms

    DOI Logo 10.17352/ijpsdr.000024

    Published On: January 29, 2020 | Pages: 001 - 005

    Author(s): Mohsen M Zareh, Monir Z Saad, Wafaa S Hassan, Mostafa E Elhennawy and Mahmoud M Sebaiy*
    Abstract View Full Article View
    mendeley

    Visible light and UV-assisted photodegradation of phenylephrine by bulk NiO and NiO immobilized on magnetic polypyrrole support

    DOI Logo 10.17352/ijpsdr.000023

    Published On: December 31, 2019 | Pages: 016 - 024

    Author(s): Hossein Faghihian and Firoozeh Torki
    Abstract View Full Article View

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR